Impact Factor
2.73
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.12
353 total citations
h5-index
23
h5 depth signal
Cited share
50.6%
166 of 328
Total citations
353
Citation footprint
Metric signal
1.14
External metric anchor
Self-citation
8.2%
29 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
292
Turkey
255
United Kingdom
199
India
175
Canada
147
Citing Fields of Research
Hematology
1,637
Clinical Laboratory Science
280
Immunology
109
Stem Cell Biology
99
Transplantation
97
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,480
Articles tracked across the journal lifetime
Indexed publication set
328
166 cited publications
Last 12 months
241
20.1 publications/month
Open access share
9.1%
22 OA publications in the last year
Leading citing country
United States
292 citing publications
Leading citing field
Hematology
1,637 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v24n1, Feb. 2001-
v24n1, Feb. 2001-
Research Focus & Classification
Indexed Subjects
Hematology
Issuing & Sponsoring Bodies
Contributor
World Apheresis Association
Contributor
European Society for Haemapheresis
Broad Categories
Hematology
MeSH Descriptors
Blood Component Removal
Blood Component Transfusion
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1016/j.transci.2026.104545
Open DOI
Familial hypercholesterolemia in pregnancy: A case of acute myocardial infarction treated with lipid apheresis
04
DOI 10.1016/j.transci.2026.104543
Open DOI
Red blood cell alloimmunization in transfused oncology patients at a high-complexity center in Colombia
05
DOI 10.1016/j.transci.2026.104544
Open DOI
Efficacy of red blood cell transfusion relative to unit haemoglobin content in adult haematology-oncology patients
06
DOI 10.1016/j.transci.2026.104539
Open DOI
From delayed recognition to long-term disease control: Eltrombopag in severe MYH9-related disease
07
DOI 10.1016/j.transci.2026.104542
Open DOI
JACIE accreditation: Evaluation at the STSH cell therapy unit
08
DOI 10.1016/j.transci.2026.104541
Open DOI
Contemporary etiologies of crossmatch-incompatible red blood cell transfusions in non-emergent settings
09
10
Bibliographical & Catalog Notes
Also issued online.